Deletion of the APOBEC3B gene strongly impacts susceptibility to falciparum malaria

Infection, Genetics and Evolution

Volumn 12, Issue 1, 2012, Pages 142-148

  Jha, Pankaj ^a   Sinha, Swapnil ^b   Kanchan, Kanika ^b   Qidwai, Tabish ^b   Narang, Ankita ^a   Singh, Prashant Kumar ^a   Pati, Sudhanshu S ^c   Mohanty, Sanjib ^c   Mishra, Saroj K ^c   Sharma, Surya K ^d   Awasthi, Shally ^e   Venkatesh, Vimala ^e   Jain, Sanjeev ^f   Basu, Analabha ^g   Xu, Shuhua ^h   Mukerji, Mitali ^a   Habib, Saman ^b  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c ISPAT GENERAL HOSPITAL   (India)

^d NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^e KING GEORGE'S MEDICAL UNIVERSITY   (India)

^f NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^g NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS   (India)

^h INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

APOBEC3B; Innate response; Malaria endemicity; Plasmodium falciparum; Structural variation

Indexed keywords

ALLELE; APOBEC3B GENE; ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE PRODUCT; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INDIA; INDIAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ALLELES; CYTIDINE DEAMINASE; ENDEMIC DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNITY, INNATE; INDIA; MALARIA VACCINES; MALARIA, FALCIPARUM; ODDS RATIO; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC;

PLASMODIUM FALCIPARUM;

EID: 83555178386     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.11.001     Document Type: Article

References (42)

1. Abudu A., Takaori-Kondo A., Izumi T., Shirakawa K., Kobayashi M., Sasada A., Fukunaga K., Uchiyama T. Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Curr. Biol. 2006, 16:1565-1570.
2. Albuquerque S.S., Carret C., Grosso A.R., Tarun A.S., Peng X., Kappe S.H., Prudencio M., Mota M.M. Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events. BMC Genomics 2009, 10:270.
3. An P., Johnson R., Phair J., Kirk G.D., Yu X.F., Donfield S., Buchbinder S., Goedert J.J., Winkler C.A. APOBEC3B deletion and risk of HIV-1 acquisition. J. Infect. Dis. 2009, 200:1054-1058.
4. Bano N., Romano J.D., Jayabalasingham B., Coppens I. Cellular interactions of Plasmodium liver stage with its host mammalian cell. Int. J. Parasitol. 2007, 37:1329-1341.
5. Bhattacharya C., Aggarwal S., Kumar M., Ali A., Matin A. Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1). PLoS ONE 2008, 3:e2315.
6. Bonvin M., Achermann F., Greeve I., Stroka D., Keogh A., Inderbitzin D., Candinas D., Sommer P., Wain-Hobson S., Vartanian J.P., Greeve J. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 2006, 43:1364-1374.
7. Bonvin M., Greeve J. Hepatitis B: modern concepts in pathogenesis-APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus. Curr. Opin. Infect Dis. 2008, 21:298-303.
8. bu-Raddad L.J., Patnaik P., Kublin J.G. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006, 314:1603-1606.
9. Cann H.M., de T.C., Cazes L., Legrand M.F., Morel V., Piouffre L., Bodmer J., Bodmer W.F., Bonne-Tamir B., Cambon-Thomsen A., Chen Z., Chu J., Carcassi C., Contu L., Du R., Excoffier L., Ferrara G.B., Friedlaender J.S., Groot H., Gurwitz D., Jenkins T., Herrera R.J., Huang X., Kidd J., Kidd K.K., Langaney A., Lin A.A., Mehdi S.Q., Parham P., Piazza A., Pistillo M.P., Qian Y., Shu Q., Xu J., Zhu S., Weber J.L., Greely H.T., Feldman M.W., Thomas G., Dausset J., Cavalli-Sforza L.L. A human genome diversity cell line panel. Science 2002, 296:261-262.
10. Cullen B.R. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 2006, 80:1067-1076.
11. Doehle B.P., Schafer A., Wiegand H.L., Bogerd H.P., Cullen B.R. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 2005, 79:8201-8207.
12. Gallup J.L., Sachs J.D. The economic burden of malaria. Am. J. Trop. Med. Hyg. 2001, 64:85-96.
13. Malaria in Europe, an ecological study 1937, Hackett, Oxford University Press.
14. Harris R.S., Liddament M.T. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 2004, 4:868-877.
15. Hay S.I., Guerra C.A., Gething P.W., Patil A.P., Tatem A.J., Noor A.M., Kabaria C.W., Manh B.H., Elyazar I.R., Brooker S., Smith D.L., Moyeed R.A., Snow R.W. A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med. 2009, 6:e1000048.
16. Genetic landscape of the people of India: a canvas for disease gene exploration. J Genet. 2008, 87:3-20. Indian Genome Variation Consortium.
17. Kaslow, R.A., McNicholl, J., Hil, A.V., 2008. Genetic Susceptibility to Infecious Diseases., p. 376.
18. Kidd J.M., Newman T.L., Tuzun E., Kaul R., Eichler E.E. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet. 2007, 203:e63.
19. Kohn J. Separation of haemoglobins on cellulose acetate. J. Clin. Pathol. 1969, 22:109-111.
20. Kublin J.G., Patnaik P., Jere C.S., Miller W.C., Hoffman I.F., Chimbiya N., Pendame R., Taylor T.E., Molyneux M.E. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005, 365:233-240.
21. Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 2005, 77:171-192.
22. Li J.Z., Absher D.M., Tang H., Southwick A.M., Casto A.M., Ramachandran S., Cann H.M., Barsh G.S., Feldman M., Cavalli-Sforza L.L., Myers R.M. Worldwide human relationships inferred from genome-wide patterns of variation. Science 2008, 319:1100-1104.
23. Li Q., Smith A.J., Schacker T.W., Carlis J.V., Duan L., Reilly C.S., Haase A.T. Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J. Immunol. 2009, 183:1975-1982.
24. Missiroli, A., 1948. Anopheles control in the Mediterranean area. pp, 1566-1575.
25. Muller I., Bockarie M., Alpers M., Smith T. The epidemiology of malaria in Papua New Guinea. Trends Parasitol. 2003, 19:253-259.
26. Nei M., Chesser R.K. Estimation of fixation indices and gene diversities. Ann. Hum. Genet. 1983, 47:253-259.
27. Patricia Schlagenhauf-Lawlor, 2001. Travelers' Malaria: People and Plasmodia: Some Historic Perspectives.
28. Patsoula E., Spanakos G., Sofianatou D., Parara M., Vakalis N.C. A single-step, PCR-based method for the detection and differentiation of Plasmodium vivax and P. falciparum. Ann. Trop. Med. Parasitol. 2003, 97:15-21.
29. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38:904-909.
30. Refsland E.W., Stenglein M.D., Shindo K., Albin J.S., Brown W.L., Harris R.S. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 2010, 38:4274-4284.
31. Renia L., Potter S.M. Co-infection of malaria with HIV: an immunological perspective. Parasite Immunol. 2006, 28:589-595.
32. Romi R., Sabatinelli G., Majori G. Could malaria reappear in Italy?. Emerg. Infect. Dis. 2001, 7:915-919.
33. Sabeti P.C., Varilly P., Fry B., Lohmueller J., Hostetter E., Cotsapas C., Xie X., Byrne E.H., McCarroll S.A., Gaudet R., Schaffner S.F., Lander E.S., Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., Leal S.M., Pasternak S., Wheeler D.A., Willis T.D., Yu F., Yang H., Zeng C., Gao Y., Hu H., Hu W., Li C., Lin W., Liu S., Pan H., Tang X., Wang J., Wang W., Yu J., Zhang B., Zhang Q., Zhao H., Zhao H., Zhou J., Gabriel S.B., Barry R., Blumenstiel B., Camargo A., Defelice M., Faggart M., Goyette M., Gupta S., Moore J., Nguyen H., Onofrio R.C., Parkin M., Roy J., Stahl E., Winchester E., Ziaugra L., Altshuler D., Shen Y., Yao Z., Huang W., Chu X., He Y., Jin L., Liu Y., Shen Y., Sun W., Wang H., Wang Y., Wang Y., Xiong X., Xu L., Waye M.M., Tsui S.K., Xue H., Wong J.T., Galver L.M., Fan J.B., Gunderson K., Murray S.S., Oliphant A.R., Chee M.S., Montpetit A., Chagnon F., Ferretti V., Leboeuf M., Olivier J.F., Phillips M.S., Roumy S., Sallee C., Verner A., Hudson T.J., Kwok P.Y., Cai D., Koboldt D.C., Miller R.D., Pawlikowska L., Taillon-Miller P., Xiao M., Tsui L.C., Mak W., Song Y.Q., Tam P.K., Nakamura Y., Kawaguchi T., Kitamoto T., Morizono T., Nagashima A., Ohnishi Y., Sekine A., Tanaka T., Tsunoda T., Deloukas P., Bird C.P., Delgado M., Dermitzakis E.T., Gwilliam R., Hunt S., Morrison J., Powell D., Stranger B.E., Whittaker P., Bentley D.R., Daly M.J., de Bakker P.I., Barrett J., Chretien Y.R., Maller J., McCarroll S., Patterson N., Pe'er I., Price A., Purcell S., Richter D.J., Sabeti P., Saxena R., Schaffner S.F., Sham P.C., Varilly P., Altshuler D., Stein L.D., Krishnan L., Smith A.V., Tello-Ruiz M.K., Thorisson G.A., Chakravarti A., Chen P.E., Cutler D.J., Kashuk C.S., Lin S., Abecasis G.R., Guan W., Li Y., Munro H.M., Qin Z.S., Thomas D.J., McVean G., Auton A., Bottolo L., Cardin N., Eyheramendy S., Freeman C., Marchini J., Myers S., Spencer C., Stephens M., Donnelly P., Cardon L.R., Clarke G., Evans D.M., Morris A.P., Weir B.S., Tsunoda T., Johnson T.A., Mullikin J.C., Sherry S.T., Feolo M., Skol A., Zhang H., Zeng C., Zhao H., Matsuda I., Fukushima Y., Macer D.R., Suda E., Rotimi C.N., Adebamowo C.A., Ajayi I., Aniagwu T., Marshall P.A., Nkwodimmah C., Royal C.D., Leppert M.F., Dixon M., Peiffer A., Qiu R., Kent A., Kato K., Niikawa N., Adewole I.F., Knoppers B.M., Foster M.W., Clayton E.W., Watkin J., Gibbs R.A., Belmont J.W., Muzny D., Nazareth L., Sodergren E., Weinstock G.M., Wheeler D.A., Yakub I., Gabriel S.B., Onofrio R.C., Richter D.J., Ziaugra L., Birren B.W., Daly M.J., Altshuler D., Wilson R.K., Fulton L.L., Rogers J., Burton J., Carter N.P., Clee C.M., Griffiths M., Jones M.C., McLay K., Plumb R.W., Ross M.T., Sims S.K., Willey D.L., Chen Z., Han H., Kang L., Godbout M., Wallenburg J.C., L'Archeveque P., Bellemare G., Saeki K., Wang H., An D., Fu H., Li Q., Wang Z., Wang R., Holden A.L., Brooks L.D., McEwen J.E., Guyer M.S., Wang V.O., Peterson J.L. Genome-wide detection and characterization of positive selection in human populations. Nature 2007, 449:913-918.
34. Sallares R., Bouwman A., Anderung C. The spread of malaria to Southern Europe in antiquity: new approaches to old problems. Med. Hist. 2004, 48:311-328.
35. Sinha S., Mishra S.K., Sharma S., Patibandla P.K., Mallick P.K., Sharma S.K., Mohanty S., Pati S.S., Mishra S.K., Ramteke B.K., Bhatt R., Joshi H., Dash A.P., Ahuja R.C., Awasthi S., Venkatesh V., Habib S. Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J. 2008, 7:13.
36. Sinha S., Qidwai T., Kanchan K., Anand P., Jha G.N., Pati S.S., Mohanty S., Mishra S.K., Tyagi P.K., Sharma S.K., Venkatesh V., Habib S. Variations in host genes encoding adhesion molecules and susceptibility to falciparum malaria in India. Malar J. 2008, 7:250.
37. Sirugo G., Hennig B.J., Adeyemo A.A., Matimba A., Newport M.J., Ibrahim M.E., Ryckman K.K., Tacconelli A., Mariani-Costantini R., Novelli G., Soodyall H., Rotimi C.N., Ramesar R.S., Tishkoff S.A., Williams S.M. Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum. Genet. 2008, 123:557-598.
38. Stenglein M.D., Harris R.S. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J. Biol. Chem. 2006, 281:16837-16841.
39. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans. R. Soc. Trop. Med. Hyg. 2000, 94(Suppl. 1):S1-90. WHO.
40. World Malaria Report 2005 2005, WHO and UNICEF, WHO.
41. Williams T.N., Mwangi T.W., Wambua S., Peto T.E., Weatherall D.J., Gupta S., Recker M., Penman B.S., Uyoga S., Macharia A., Mwacharo J.K., Snow R.W., Marsh K. Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat. Genet. 2005, 37:1253-1257.
42. Zhang W., Zhang X., Tian C., Wang T., Sarkis P.T., Fang Y., Zheng S., Yu X.F., Xu R. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression. Cell. Microbiol. 2008, 10:112-121.